Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.39 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.39 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.38 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.38 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.37 |
| ▸ | LTA4H | P09960 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4585237 | 1.00 | GABRR1 (0.46) | GABRR1CYP1A2TP53FOLH1NAALAD2 | |
| SCHEMBL11128953 | 0.92 | GABRR1 (0.41) | GABRR1CYP1A2TP53FOLH1NAALAD2 | |
| SCHEMBL11128951 | 0.92 | GABRR1 (0.41) | GABRR1CYP1A2TP53FOLH1NAALAD2 | |
| SCHEMBL10688481 | 0.90 | GRIK1 (0.50) | GABRR1CYP1A2FOLH1NAALAD2ENPEP | |
| SCHEMBL6908844 | 0.90 | GRIK1 (0.50) | GABRR1CYP1A2FOLH1NAALAD2ENPEP | |
| SCHEMBL16744146 | 0.90 | GRIK1 (0.50) | GABRR1CYP1A2FOLH1NAALAD2ENPEP | |
| SCHEMBL18571367 | 0.90 | GRIK1 (0.50) | GABRR1CYP1A2FOLH1NAALAD2ENPEP | |
| SCHEMBL10995391 | 0.88 | GABRR1 (0.38) | GABRR1CYP1A2TP53FOLH1NAALAD2 | |
| SCHEMBL10995441 | 0.88 | GABRR1 (0.38) | GABRR1CYP1A2TP53FOLH1NAALAD2 | |
| SCHEMBL5314429 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7470822-B2 | 2,7-Dimethyl-4-octenedial, which can be efficiently utilized in the synthesis of carotenoid compounds containing the conjugated polyene chain of beta-carotene by the double elimination reaction without going through the Ramberg-Backlund reaction; use in food additives and nutraceuticals | MYONGJI UNIVERSITY INDUSTRY AND ACADEMIA COOPERATION (KR) | 2008-12-30 | — | — | US | claimed |
| US-20080262271-A1 | 2,7-Dimethyl-4-octenedial, which can be efficiently utilized in the synthesis of carotenoid compounds containing the conjugated polyene chain of beta-carotene by double elimination reaction without going through the Ramberg-Backlund reaction; use in food additives and nutraceuticals | MYONGJI UNIVERSITY INDUSTRY AND ACADEMIA COOPERATION (KP) | 2008-10-23 | — | — | US | claimed |
| WO-2006038764-A1 | ClO DIALDEHYDE, SYNTHETIC METHOD THEREOF, AND SYNTHETIC METHOD OF BETA-CAROTENE USING THE SAME | KOO SANGHO (KR) | 2006-04-13 | — | — | WO | claimed |
| US-7470822-B2 | 2,7-Dimethyl-4-octenedial, which can be efficiently utilized in the synthesis of carotenoid compounds containing the conjugated polyene chain of beta-carotene by the double elimination reaction without going through the Ramberg-Backlund reaction; use in food additives and nutraceuticals | MYONGJI UNIVERSITY INDUSTRY AND ACADEMIA COOPERATION (KR) | 2008-12-30 | — | — | US | disclosed |
| US-20080262271-A1 | 2,7-Dimethyl-4-octenedial, which can be efficiently utilized in the synthesis of carotenoid compounds containing the conjugated polyene chain of beta-carotene by double elimination reaction without going through the Ramberg-Backlund reaction; use in food additives and nutraceuticals | MYONGJI UNIVERSITY INDUSTRY AND ACADEMIA COOPERATION (KP) | 2008-10-23 | — | — | US | disclosed |
| WO-2006038764-A1 | ClO DIALDEHYDE, SYNTHETIC METHOD THEREOF, AND SYNTHETIC METHOD OF BETA-CAROTENE USING THE SAME | KOO SANGHO (KR) | 2006-04-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080262271-A1 | 2,7-Dimethyl-4-octenedial, which can be efficiently utilized in the synthesis of carotenoid compounds containing the conjugated polyene chain of beta-carotene by double elimination reaction without going through the Ramberg-Backlund reaction; use in food additives and nutraceuticals | DHCR24, SBDS, HBB | GABRR1 3635/4885CYP1A2 312/4885TP53 4395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.